No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Financial - Credit Services
Genertec Universal Medical Group Company Limited, founded in 1984 and based in Beijing, China, provides extensive financing and advisory services across the People's Republic of China, alongside operating a significant healthcare business. The company's operations are segmented into two primary divisions. The Finance and Advisory segment delivers a range of services including direct finance leasing, sale-and-leaseback arrangements, factoring, operating leases, and various advisory offerings. Meanwhile, its Hospital Group segment focuses on providing medical care, managing hospitals and healthcare facilities, and conducting import, export, and general trading of medical-related goods. Beyond these core areas, Genertec Universal Medical also engages in medical technology development, hospital digitalization, construction, and management services, as well as property management and medical consulting. The company serves a diverse clientele, encompassing patients, hospitals, medical equipment suppliers, and other public sector organizations. In July 2018, the company adopted its current name, having previously operated as Universal Medical Financial & Technical Advisory Services Company Limited.
www.umcare.cnNo one on the platform currently holds 2666.HK.
No tracked institution reports a position in 2666.HK as of their last filing.
No one on the platform has traded 2666.HK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 14.4% | 8.8% | 6.8% | — | — | — |
| Rev. Growth % | 6.4% | 12.0% | ||||
| Profit Margin % | 15.2% | 16.7% | 22.5% | |||
| Free Cash Flow Margin % | 21.2% | 8.8% | -37.4% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $15.1B | +3.2% | $1.14 | $1.14–$1.14 | — | 1 |
| 2027 | $15.3B | +1.2% | $1.17 | $1.17–$1.18 | — | 1 |
| 2028 | $15.6B | +2.4% | $1.22 | $0.39–$2.04 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| $44.70 |
| -1.63% |
| $14.3B |
| — |
| 1216.HKZhongyuan Bank Co., Ltd. | $0.28 | +0.00% | $10.4B | — |
| 1905.HKHaitong Unitrust International Financial Leasing Co., Ltd. | $0.97 | -8.02% | $8.0B | — |
Source: Financial Modeling Prep · peers by sector/industry